Alvotech provides Stelara biosimilar supply to Fuji Pharma 17-Apr-2019 By Ben Hargreaves Fuji Pharma signs agreement to receive an exclusive supply of the ustekinumab biosimilar for the Japanese market, furthering a previous investment agreement.